# Hoth Therapeutics (HOTH) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/HOTH
## Company Profile
- Ticker: HOTH
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
- Tags: Oncology
## Stock Data
- Close: 1.36 USD
- Market cap: 26013594.48 USD
- Last updated: 2026-05-27
## Business Overview
Hoth Therapeutics is a biotechnology company focused on developing therapies across dermatology, inflammation, and oncology. Its story is built around a broad but still early-stage development portfolio.
## Why The Stock Is Moving

Current closing-price context is not available for HOTH.

## Geographic Base

Hoth is headquartered in the United States and listed on NASDAQ. It sits in small-cap specialty biopharma.

## Business Model

The company depends on preclinical and early clinical progress, capital efficiency, and the ability to prioritize programs. Investors usually watch proof-of-concept data and strategic changes.

## Landscape Position

Hoth occupies a speculative small-cap biotech niche. Its stock tends to move on program updates because the company is still shaping its identity.

## Future Catalysts

- Hoth’s catalysts are its dermatology and inflammatory-disease programs, plus any strategic update that clarifies which assets still matter. The market will care about whether the company can keep a viable development path.

## Recent News
- 2019-02-25 13:00 EST — [Hoth Therapeutics Inc. Announces the Addition of Dr. Adam Friedman, M.D. to the Company's Scientific Advisory Board](https://biopharmsignal.com/news/HOTH/hoth-therapeutics-inc-announces-the-addition-of-dr-adam-friedman-m-d-to-the-comp-cfc21d76) — Source: Hoth Therapeutics
- 2019-02-20 22:15 EST — [Hoth Therapeutics Inc. Announces Closing of Initial Public Offering](https://biopharmsignal.com/news/HOTH/hoth-therapeutics-inc-announces-closing-of-initial-public-offering-f8957759) — Source: Hoth Therapeutics
- 2019-02-15 13:00 EST — [Hoth Therapeutics Inc. Announces Pricing of Initial Public Offering and Trading on the Nasdaq Capital Market Under the Ticker Symbol “HOTH”](https://biopharmsignal.com/news/HOTH/hoth-therapeutics-inc-announces-pricing-of-initial-public-offering-and-trading-o-4961a8d6) — Source: Hoth Therapeutics